Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Eql Pharma AB

Closing information (x1000 NOK)

Closing information 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Turnover 392,934 Less Arrow 268,156 Less Arrow 261,107
Financial expenses 13,699 Less Arrow 5,819 Less Arrow 2,383
Earnings before taxes 57,180 Less Arrow 29,036 More Arrow 39,147
EBITDA 84,201 Less Arrow 41,999 More Arrow 49,853
Total assets 850,871 Less Arrow 379,402 Less Arrow 287,008
Current assets 421,060 Less Arrow 200,760 Less Arrow 167,996
Current liabilities 232,508 Less Arrow 164,497 Less Arrow 116,509
Equity capital 232,526 Less Arrow 180,409 Less Arrow 155,464
- share capital 1,376 Less Arrow 1,328 Less Arrow 1,314
Employees (average) 21 Equal arrow 21 Less Arrow 18

Financial ratios

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Solvency 27.3% More Arrow 47.6% More Arrow 54.2%
Turnover per employee 18,711 Less Arrow 12,769 More Arrow 14,506
Profit as a percentage of turnover 14.6% Less Arrow 10.8% More Arrow 15.0%
Return on assets (ROA) 8.3% More Arrow 9.2% More Arrow 14.5%
Current ratio 181.1% Less Arrow 122.0% More Arrow 144.2%
Return on equity (ROE) 24.6% Less Arrow 16.1% More Arrow 25.2%
Change turnover 115,033 Less Arrow 4,319 Less Arrow -150,528
Change turnover % 41% Less Arrow 2% Less Arrow -37%
Chg. No. of employees 0 More Arrow 3 More Arrow 5
Chg. No. of employees % 0% More Arrow 17% More Arrow 38%

Total value of public sale

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.